Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01687985 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01687985 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 81 participants.
The verdict
NCT01687985, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.
Interventions
- DRUG BLI801 laxative - low dose
- DRUG BLI801 laxative - high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01687985
The ClinicalTrials.gov registry entry for NCT01687985 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI801 laxative - low dose is the first listed.
NCT01687985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01687985 about?
NCT01687985 is a clinical study titled "A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults". A pilot study to evaluate the safety and efficacy of multiple BLI801 doses in constipated adults.
What is the current status of trial NCT01687985?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2012-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01687985?
The interventions under investigation include: BLI801 laxative - low dose (DRUG), BLI801 laxative - high dose (DRUG).
Who is sponsoring clinical trial NCT01687985?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.